BC
PFE icon

Barrett & Company’s Pfizer PFE Stock Holding History

Barrett & Company’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$366K Buy
13,030
+1
+0% +$27 0.13% 100
2025
Q4 		$324K Sell
13,029
-1,448
-10% -$36.5K 0.11% 104
2025
Q3 		$369K Buy
14,477
+13
+0.1% +$321 0.13% 99
2025
Q2 		$351K Sell
14,464
-87
-0.6% -$2.03K 0.13% 104
2025
Q1 		$369K Buy
14,551
+104
+0.7% +$2.72K 0.16% 96
2024
Q4 		$383K Buy
14,447
+13
+0.1% +$353 0.16% 87
2024
Q3 		$418K Sell
14,434
-54
-0.4% -$1.57K 0.18% 85
2024
Q2 		$405K Sell
14,488
-882
-6% -$24.3K 0.18% 82
2024
Q1 		$427K Sell
15,370
-88
-0.6% -$2.44K 0.2% 83
2023
Q4 		$445K Sell
15,458
-878
-5% -$26.5K 0.24% 82
2023
Q3 		$542K Buy
16,336
+149
+0.9% +$5.27K 0.32% 62
2023
Q2 		$594K Buy
16,187
+10
+0.1% +$389 0.34% 59
2023
Q1 		$660K Buy
16,177
+581
+4% +$25.1K 0.42% 53
2022
Q4 		$799K Hold
15,596
– – 0.53% 44
2022
Q3 		$799K Buy
+15,596
New +$758K 0.53% 44

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Barrett & Company's PFE Position: Q1 2026 in Review

Barrett & Company increased its Pfizer (PFE) stake by 0.01% in Q1 2026, buying an estimated $27 and bringing the position to 13,030 shares worth $366K. The position accounts for 0.13% of the portfolio, ranked #100.

Barrett & Company first reported a position in PFE in Q3 2022 and has held it in 15 quarters since. The position peaked at $799K in Q4 2022. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Barrett & Company held 13,030 shares of Pfizer worth $366K as of Q1 2026.
  • Barrett & Company bought 1 Pfizer share in Q1 2026, an estimated $27.
  • Pfizer made up 0.13% of Barrett & Company's portfolio in Q1 2026, its #100 holding.
  • Barrett & Company first reported a position in Pfizer in Q3 2022 and has held it in 15 quarters since.
  • Barrett & Company's Pfizer position peaked at $799K in Q4 2022.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Barrett & Company's 13F filing for Q1 2026, filed 4 May 2026.